Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-31FDA Approved: GLATIRAMER ACETATE — Original Application (UPSHER-SMITH LABORATORIES, LLC)
FDA approved the original application for glatiramer acetate injection from Upsher-Smith Laboratories, establishing a generic version of the…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Effect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia Activation [Phase 4]
Phase 4 trial evaluating whether ocrelizumab reduces neuroinflammation in multiple sclerosis as measured by 11C-PBR28 MR-PET imaging of micr…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)
Beijing Tiantan Hospital is conducting an ongoing enrollment study to establish normal Chinese lifespan brain charts, enrolling by invitatio…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases [NA]
A Mayo Clinic-led clinical trial investigates breathing practices to support brain and mental health in cancer and neurodegenerative disease…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update on implementing an advanced telerehabilitation solution for people with multiple sclerosis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: The Validity and Reliability of the Modified O'Sullivan Functional Balance (mOFB) Test for Multiple Sclerosis
This clinical trial update reports on the validity and reliability of the Modified O'Sullivan Functional Balance (mOFB) test for assessing b…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Smoldering Inflammation in MS
A clinical trial at Washington University School of Medicine is investigating smoldering inflammation in people with multiple sclerosis and …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
A prospective investigation of Multiple Sclerosis in the Three Rivers Region is currently recruiting participants, sponsored by the Universi…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent [Phase 2]
Phase 2 ascending-dose study of RVP-001, a manganese-based MRI contrast agent, completed to assess safety and preliminary efficacy in CNS le…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Probiotic Intervention for People With Multiple Sclerosis [NA]
A clinical trial evaluating a probiotic intervention for people with multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
This entry summarizes an ongoing, recruiting prospective cohort study (Clinnova-MS) evaluating outcomes in people with multiple sclerosis in…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder
A clinical trial update from Assiut University describes a study comparing multiple sclerosis and neuromyelitis optica spectrum disorder, wi…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities [Phase 4]
A Phase 4 clinical trial is evaluating individualized cryoneurolysis to manage pain in the context of spasticity in the upper and lower extr…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Emotions in Multiple Sclerosis [NA]
A completed clinical trial examining emotions in people with multiple sclerosis, sponsored by Lille Catholic University.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Intermediate Expanded Access Protocol CNMAu8.EAP03
Clene Nanomedicine's intermediate expanded access protocol CNMAu8.EAP03 for CNM-Au8 in multiple sclerosis is temporarily not available. No c…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials
A completed clinical trial assessing how well healthcare professionals and multiple sclerosis patients understand risk management plan (RMP)…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults [Phase 4]
This Phase 4 trial assessed the humoral immune response to the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in immunocompromised adults compa…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
A clinical trial is evaluating a new PET radiotracer, [18F]-FZTA, to detect brain inflammation and will enroll healthy young adults and indi…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Implication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple Sclerosis
This clinical trial update investigates whether the 5-HT7 receptor plays a role in inflammatory mechanisms in multiple sclerosis; the study …
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis. [NA]
A clinical trial in recruitment is studying transcutaneous tibial neuro-stimulation to improve voiding dysfunction in individuals with multi…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Project BIPAMS: Behavioral Intervention for Physical Activity in Multiple Sclerosis [NA]
This clinical trial update notes an active non-recruiting study (Project BIPAMS) evaluating a behavioral intervention to increase physical a…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Effect of Visually-Guided Gait Training on Balance, Mobility and Risk of Falling in Patients With Multiple Sclerosis [NA]
This clinical trial update describes the status of a study examining whether visually-guided gait training improves balance, mobility, and r…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years [Phase 2]
Phase 2 clinical trial to evaluate relapse prevention in multiple sclerosis using mRNA-1195 versus placebo; currently recruiting in adults a…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis [NA]
Clinical trial update from University of Alabama at Birmingham on a behavioral intervention for improving physical activity and addressing s…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis [NA]
A completed clinical trial investigated the effects of motor imagery and action observation in people with multiple sclerosis.